December 5, 2019 Another proposed class action claims the maker of now-recalled Biocell textured breast implants failed to warn patients that the product could increase their risk of developing cancer.
October 9, 2019 Allergan faces more potential class action litigation over its recalled Biocell textured breast implants' connection to BIA-ALCL, a cancer of the immune system.
September 25, 2019 Allergan PLC is on the receiving end of a proposed class action lawsuit centered on a potential merger with AbbVie, Inc., the details of which the case alleges were not fully disclosed to stockholders.
June 13, 2019 Two healthcare plans have joined the ranks of those suing Big Pharma heavyweights over their alleged contributions to the national opioid crisis that has devastated the nation.
April 26, 2018 Another proposed class action filed on behalf of children born with Neonatal Abstinence Syndrome accuses a group of pharmaceutical companies and distributors of contributing to the 'opioid epidemic' that has swept across the state of Louisiana.
April 12, 2018 Three municipalities have sued a group of 11 pharmaceutical companies claiming towns and cities in Pennsylvania have suffered 'a public health and safety crisis' as a result of the defendants’ alleged misrepresentation of their opioid medications.
March 30, 2018 Another proposed class action filed on behalf of a minor child diagnosed with NAS has been added to the multidistrict litigation involving pharmaceutical companies’ and distributors’ alleged contributions to the country’s growing 'opioid epidemic.'
March 9, 2018 A growing number of lawsuits have been filed against a group of pharmaceutical companies and distributors over claims that the defendants have caused a national health crisis by deceptively marketing opioids for long-term use.
March 7, 2018 Another proposed class action has been filed against a group of 22 pharmaceutical companies and distributors over claims that the defendants’ deceptive marketing scheme and negligence have fueled the nation’s growing opioid crisis.
March 6, 2018 A group of 20 pharmaceutical companies and distributors has been named in a proposed class action lawsuit filed on behalf of a newborn baby who the suit claims suffers from neonatal abstinence syndrome (NAS) as a result of the defendants’ actions.
December 5, 2017 Three Mississippi hospitals claim the conduct of 19 pharma-industry heavyweights contributed greatly to the nation's opioid abuse epidemic.
November 16, 2017 Another proposed class action has been filed against various pharmaceutical companies and distributors, claiming the defendants’ deceptive marketing of opioid products has contributed to their widespread abuse.
November 16, 2017 A proposed class action has been filed against a group of pharmaceutical companies and distributors over claims that they deceptively marketed and sold opioids without fully disclosing their associated risks.
